Assess whether to escalate a case to peer review (efe63d)

SITUATION Risk-model validation lead is responsible for to escalate a case to peer review in a unit, using a new early-warning model with unexpected mortality case series as the only working extract. A Joint Commission tracer on sepsis is what reset the timeline for this Healthcare Models and Documentation file.

DECISION Risk-model validation lead in a unit with a new early-warning model must choose Proceed under protocol / Pause the pathway / Escalate safety review / Hold using unexpected mortality case series after a Joint Commission tracer on sepsis.

HYPOTHESES TO TEST 1. The population in unexpected mortality case series is the one a Joint Commission tracer on sepsis named, so Proceed under protocol follows for this Models and Documentation file. 2. The population in unexpected mortality case series is adjacent only to a Joint Commission tracer on sepsis; Pause the pathway is the honest Healthcare call. 3. A unit with a new early-warning model already contained a Joint Commission tracer on sepsis before unexpected mortality case series arrived; no new Models and Documentation path. 4. Provenance on unexpected mortality case series after a Joint Commission tracer on sepsis is broken; do not pick Proceed under protocol or Pause the pathway yet.

ANALYSIS REQUIRED 1. Trace access logs and outputs to the rule risk-model validation lead must apply. 2. Assess patient-safety and HIPAA / minimum-necessary implications of to escalate a case to peer review. 3. Quantify who is harmed if unexpected mortality case series is wrong. 4. For this Healthcare Models and Documentation file, read unexpected mortality case series against a Joint Commission tracer on sepsis and write the one fact that would move to escalate a case to peer review for risk-model validation lead.

RECOMMENDATION Choose Proceed under protocol / Pause the pathway / Escalate safety review / Hold on this Healthcare / Models and Documentation packet (unexpected mortality case series after a Joint Commission tracer on sepsis). If unexpected mortality case series cannot force a Healthcare label under Models and Documentation, stop. Do not invent missing evidence a unit with a new early-warning model does not have.

COMMAND RETURNS - Bottom-line Healthcare option on to escalate a case to peer review, then the evidence in unexpected mortality case series, then the action for risk-model validation lead - Hypothesis scorecard against unexpected mortality case series: supported / rejected / untestable - What changes to escalate a case to peer review if a Joint Commission tracer on sepsis is later withdrawn - Named option among Proceed under protocol, Pause the pathway, Escalate safety review and the fact that kills the others